{"transactions":[{"id":973341,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2025-12-11T21:34:24.000Z","date":"2025-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2552,"price":701.51,"value":1790253.52,"ownership":{"direct":true},"balance_after":21673,"source":{"system":"sec-edgar","filing":"0001411984-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000141198425000007/edgardoc.xml","form_type":"4"}},{"id":976913,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-09T21:31:12.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":18315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":18315,"derivative":{"exercise_price":726.71,"expiration_date":"2035-12-05","underlying":"Common Stock","underlying_shares":18315},"source":{"system":"sec-edgar","filing":"0001411984-25-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000141198425000005/edgardoc.xml","form_type":"4"}},{"id":976912,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2025-12-09T21:31:12.000Z","date":"2025-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1906,"price":712.94,"value":1358863.64,"ownership":{"direct":true},"balance_after":24225,"source":{"system":"sec-edgar","filing":"0001411984-25-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000141198425000005/edgardoc.xml","form_type":"4"}},{"id":976911,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2025-12-09T21:31:12.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":3715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029."}],"balance_after":26131,"source":{"system":"sec-edgar","filing":"0001411984-25-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000141198425000005/edgardoc.xml","form_type":"4"}},{"id":1327437,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-12-18T21:03:11.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":969,"price":730.81,"value":708154.89,"ownership":{"direct":true},"balance_after":34792,"source":{"system":"sec-edgar","filing":"0001968202-24-000142","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000142/edgardoc.xml","form_type":"4"}},{"id":1338114,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-10T21:03:18.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":13472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":13472,"derivative":{"exercise_price":771.64,"expiration_date":"2034-12-06","underlying":"Common Stock","underlying_shares":13472},"source":{"system":"sec-edgar","filing":"0001883850-24-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000049/edgardoc.xml","form_type":"4"}},{"id":1338113,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:18.000Z","date":"2024-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":492,"price":787,"value":387204.0,"ownership":{"direct":true},"balance_after":35761,"source":{"system":"sec-edgar","filing":"0001883850-24-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000049/edgardoc.xml","form_type":"4"}},{"id":1338112,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:18.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":3499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028."}],"balance_after":36253,"source":{"system":"sec-edgar","filing":"0001883850-24-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000049/edgardoc.xml","form_type":"4"}},{"id":1639681,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":200,"price":951.77,"value":190354.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":20378,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639680,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":375,"price":950.45,"value":356418.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":20578,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639679,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":112,"price":949.07,"value":106295.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":20953,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639678,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":150,"price":948.7,"value":142305.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":21065,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639677,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":240,"price":947.81,"value":227474.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":21215,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639676,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":95,"price":945.81,"value":89851.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":21455,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639675,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":620,"price":944.3,"value":585466.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":21550,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639674,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":2691,"price":943.51,"value":2538985.41,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":22170,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639673,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":275,"price":941.41,"value":258887.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":24861,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639672,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":4261,"price":940.44,"value":4007214.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":25136,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639671,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":750,"price":939.6,"value":704700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":29397,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639670,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":226,"price":938.13,"value":212017.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":30147,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1639669,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-16T21:15:32.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":439,"price":937.94,"value":411755.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price."}],"balance_after":30373,"source":{"system":"sec-edgar","filing":"0001968202-24-000066","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000066/edgardoc.xml","form_type":"4"}},{"id":1647480,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-13T21:04:28.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":381.4,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":23125},"source":{"system":"sec-edgar","filing":"0001968202-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000064/edgardoc.xml","form_type":"4"}},{"id":1647479,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-13T21:04:28.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":12250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":12250,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":12250},"source":{"system":"sec-edgar","filing":"0001968202-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000064/edgardoc.xml","form_type":"4"}},{"id":1647478,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-13T21:04:28.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":16341,"price":951.68,"value":15551402.88,"ownership":{"direct":true},"balance_after":30812,"source":{"system":"sec-edgar","filing":"0001968202-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000064/edgardoc.xml","form_type":"4"}},{"id":1647477,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-13T21:04:28.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":23125,"price":381.4,"value":8819875.0,"ownership":{"direct":true},"balance_after":47153,"source":{"system":"sec-edgar","filing":"0001968202-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000064/edgardoc.xml","form_type":"4"}},{"id":1647476,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-13T21:04:28.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":8600,"price":951.68,"value":8184448.0,"ownership":{"direct":true},"balance_after":24028,"source":{"system":"sec-edgar","filing":"0001968202-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000064/edgardoc.xml","form_type":"4"}},{"id":1647475,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2024-02-13T21:04:28.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":12250,"price":372.46,"value":4562635.0,"ownership":{"direct":true},"balance_after":32628,"source":{"system":"sec-edgar","filing":"0001968202-24-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000064/edgardoc.xml","form_type":"4"}},{"id":1715295,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-12T21:05:30.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":11473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":11473,"derivative":{"exercise_price":843.79,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":11473},"source":{"system":"sec-edgar","filing":"0001883850-23-000091","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000091/edgardoc.xml","form_type":"4"}},{"id":1715294,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-12-12T21:05:30.000Z","date":"2023-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":669,"price":844.09,"value":564696.21,"ownership":{"direct":true},"balance_after":20378,"source":{"system":"sec-edgar","filing":"0001883850-23-000091","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000091/edgardoc.xml","form_type":"4"}},{"id":1715293,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-12-12T21:05:30.000Z","date":"2023-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2552,"price":844.09,"value":2154117.68,"ownership":{"direct":true},"balance_after":21047,"source":{"system":"sec-edgar","filing":"0001883850-23-000091","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000091/edgardoc.xml","form_type":"4"}},{"id":1715292,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-12-12T21:05:30.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":3199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2025 and 50% on December 8, 2027."}],"balance_after":23599,"source":{"system":"sec-edgar","filing":"0001883850-23-000091","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000091/edgardoc.xml","form_type":"4"}},{"id":1715291,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-12-12T21:05:30.000Z","date":"2023-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1108,"price":843.79,"value":934919.32,"ownership":{"direct":true},"balance_after":20400,"source":{"system":"sec-edgar","filing":"0001883850-23-000091","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000091/edgardoc.xml","form_type":"4"}},{"id":1797071,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":false,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":23125,"derivative":{"exercise_price":381.4,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":23125},"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797070,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":2534,"price":844.27,"value":2139380.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 2,534 shares of Company stock on August 24, 2023 at prices ranging from $844.02 to $844.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":21508,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797069,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":759,"price":843.31,"value":640072.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 759 shares of Company stock on August 24, 2023 at prices ranging from $843.04 to $843.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":24042,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797068,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":617,"price":842.66,"value":519921.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 617 shares of Company stock on August 24, 2023 at prices ranging from $842.28 to $842.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":24801,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797067,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":363,"price":841.15,"value":305337.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 363 shares of Company stock on August 24, 2023 at prices ranging from $841.03 to $841.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":25418,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797066,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":46,"price":840.74,"value":38674.04,"ownership":{"direct":true},"balance_after":25781,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797065,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":148,"price":839.28,"value":124213.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 148 shares of Company stock on August 24, 2023 at prices ranging from $839.08 to $839.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":25827,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797064,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":667,"price":838.37,"value":559192.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 667 shares of Company stock on August 24, 2023 at prices ranging from $838.06 to $838.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":25975,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797063,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":300,"price":837.53,"value":251259.0,"ownership":{"direct":true},"balance_after":26642,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797062,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":625,"price":836.32,"value":522700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 625 shares of Company stock on August 24, 2023 at prices ranging from $836.10 to $836.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":26942,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797061,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-24","kind":"sale","planned":false,"acquired":false,"shares":138,"price":835.67,"value":115322.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 138 shares of Company stock on August 24, 2023 at prices ranging from $835.58 to $835.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price."}],"balance_after":27567,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797060,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":16928,"price":842.66,"value":14264548.48,"ownership":{"direct":true},"balance_after":27705,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":1797059,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2023-08-25T20:02:12.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":true,"shares":23125,"price":381.4,"value":8819875.0,"ownership":{"direct":true},"balance_after":44633,"source":{"system":"sec-edgar","filing":"0001968202-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000028/edgardoc.xml","form_type":"4"}},{"id":2080320,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-20T21:09:59.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":14019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":14019,"derivative":{"exercise_price":726.53,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":14019},"source":{"system":"sec-edgar","filing":"0001883850-22-000137","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000137/edgardoc.xml","form_type":"4"}},{"id":2080319,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-12-20T21:09:59.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":3798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026."}],"balance_after":33884,"source":{"system":"sec-edgar","filing":"0001883850-22-000137","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000137/edgardoc.xml","form_type":"4"}},{"id":2088762,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-12-13T21:10:50.000Z","date":"2022-12-09","kind":"tax_withholding","acquired":false,"shares":492,"price":753.28,"value":370613.76,"ownership":{"direct":true},"balance_after":30086,"source":{"system":"sec-edgar","filing":"0001883850-22-000118","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000118/edgardoc.xml","form_type":"4"}},{"id":2104651,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-22","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":378.98,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104650,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":1,"price":748.17,"value":748.17,"ownership":{"direct":true},"balance_after":30578,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104649,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":629,"price":747.28,"value":470039.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 629 shares of Company stock on November 23, 2022 at prices ranging from $747.05 to $747.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":30579,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104648,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":1164,"price":746.42,"value":868832.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 1,164 shares of Company stock on November 23, 2022 at prices ranging from $746.26 to $746.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":31208,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104647,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":256,"price":745.56,"value":190863.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 256 shares of Company stock on November 23, 2022 at prices ranging from $745.07 to $745.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":32372,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104646,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":780,"price":744.56,"value":580756.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 780 shares of Company stock on November 23, 2022 at prices ranging from $744.42 to $744.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":32628,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104645,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":101,"price":743.66,"value":75109.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 101 shares of Company stock on November 23, 2022 at prices ranging from $743.24 to $743.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":33408,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104644,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":99,"price":742.58,"value":73515.42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 99 shares of Company stock on November 23, 2022 at prices ranging from $742.56 to $742.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":33509,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104643,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":1002,"price":741.34,"value":742822.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 1,002 shares of Company stock on November 23, 2022 at prices ranging from $741.00 to $741.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":33608,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104642,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":1808,"price":740.29,"value":1338444.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 1,808 shares of Company stock on November 23, 2022 at prices ranging from $740.00 to $740.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":34610,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104641,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":3124,"price":739.48,"value":2310135.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 3,124 shares of Company stock on November 23, 2022 at prices ranging from $739.00 to $739.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":36418,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104640,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":944,"price":738.57,"value":697210.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 944 shares of Company stock on November 23, 2022 at prices ranging from $738.07 to $738.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":39542,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104639,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":373,"price":737.37,"value":275039.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 373 shares of Company stock on November 23, 2022 at prices ranging from $737.01 to $737.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":40486,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104638,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":1005,"price":736.46,"value":740142.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 1,005 shares of Company stock on November 23, 2022 at prices ranging from $736.00 to $736.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":40859,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104637,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":686,"price":735.57,"value":504601.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 686 shares of Company stock on November 23, 2022 at prices ranging from $735.11 to $735.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 23, 2022 at each separate price."}],"balance_after":41864,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104636,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-22","kind":"tax_withholding","acquired":false,"shares":38028,"price":741.81,"value":28209550.68,"ownership":{"direct":true},"balance_after":42550,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2104635,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-25T18:07:45.000Z","date":"2022-11-22","kind":"exercise","acquired":true,"shares":50000,"price":378.98,"value":18949000.0,"ownership":{"direct":true},"balance_after":80578,"source":{"system":"sec-edgar","filing":"0001883850-22-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000098/edgardoc.xml","form_type":"4"}},{"id":2122812,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-04","kind":"exercise","acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":381.92,"expiration_date":"2026-12-16","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122811,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":404,"price":747.2,"value":301868.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 404 shares of Company stock on November 7, 2022 at prices ranging from $747.00 to $747.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price."}],"balance_after":30578,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122810,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":2782,"price":746.56,"value":2076929.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 2,782 shares of Company stock on November 7, 2022 at prices ranging from $746.15 to $746.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price."}],"balance_after":30982,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122809,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":1468,"price":745.51,"value":1094408.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 1,468 shares of Company stock on November 7, 2022 at prices ranging from $745.00 to $745.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price."}],"balance_after":33764,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122808,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":2032,"price":744.61,"value":1513047.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 2,032 shares of Company stock on November 7, 2022 at prices ranging from $744.02 to $744.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price."}],"balance_after":35232,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122807,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":1100,"price":743.39,"value":817729.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 7, 2022 at prices ranging from $743.00 to $743.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price."}],"balance_after":37264,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122806,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":100,"price":742.79,"value":74279.0,"ownership":{"direct":true},"balance_after":38364,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122805,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-04","kind":"tax_withholding","acquired":false,"shares":26114,"price":725.84,"value":18954585.76,"ownership":{"direct":true},"balance_after":38464,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2122804,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-11-08T21:00:44.000Z","date":"2022-11-04","kind":"exercise","acquired":true,"shares":34000,"price":381.92,"value":12985280.0,"ownership":{"direct":true},"balance_after":64578,"source":{"system":"sec-edgar","filing":"0001883850-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000092/edgardoc.xml","form_type":"4"}},{"id":2160660,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-09","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":555.67,"expiration_date":"2025-12-16","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160659,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":79,"price":722.83,"value":57103.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":30578,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160658,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":174,"price":721.38,"value":125520.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":30657,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160657,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":181,"price":720.41,"value":130394.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 181 shares of Company stock on September 12, 2022 at prices ranging from $720.35 to $720.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":30831,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160656,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":159,"price":719.72,"value":114435.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 159 shares of Company stock on September 12, 2022 at prices ranging from $719.66 to $719.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":31012,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160655,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":435,"price":718.5,"value":312547.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 435 shares of Company stock on September 12, 2022 at prices ranging from $718.00 to $718.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":31171,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160654,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":647,"price":717.59,"value":464280.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 647 shares of Company stock on September 12, 2022 at prices ranging from $717.00 to $717.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":31606,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160653,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":1052,"price":716.28,"value":753526.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 1,052 shares of Company stock on September 12, 2022 at prices ranging from $716.04 to $716.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":32253,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160652,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":861,"price":715.39,"value":615950.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 861 shares of Company stock on September 12, 2022 at prices ranging from $715.00 to $715.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":33305,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160651,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":267,"price":714.42,"value":190750.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 267 shares of Company stock on September 12, 2022 at prices ranging from $714.29 to $714.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":34166,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160650,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":572,"price":713.67,"value":408219.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 572 shares of Company stock on September 12, 2022 at prices ranging from $713.01 to $713.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":34433,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160649,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":110,"price":712.44,"value":78368.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 110 shares of Company stock on September 12, 2022 at prices ranging from $712.39 to $712.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":35005,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160648,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":70,"price":711.85,"value":49829.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 70 shares of Company stock on September 12, 2022 at prices ranging from $711.83 to $711.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":35115,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160647,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":2,"price":710.25,"value":1420.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":35185,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160646,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":87,"price":709.93,"value":61763.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 87 shares of Company stock on September 12, 2022 at prices ranging from $709.60 to $709.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 12, 2022 at each separate price."}],"balance_after":35187,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160645,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-09","kind":"tax_withholding","acquired":false,"shares":35304,"price":730.96,"value":25805811.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":35274,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2160644,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-09-13T20:04:00.000Z","date":"2022-09-09","kind":"exercise","acquired":true,"shares":40000,"price":555.67,"value":22226800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":70578,"source":{"system":"sec-edgar","filing":"0001883850-22-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000070/edgardoc.xml","form_type":"4"}},{"id":2376245,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":399.66,"expiration_date":"2024-12-16","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376244,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":1015,"price":618.16,"value":627432.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 1,015 shares of Company stock on February 23, 2022 at prices ranging from $618.00 to $618.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":30578,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376243,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":1176,"price":617.48,"value":726156.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 1,176 shares of Company stock on February 23, 2022 at prices ranging from $617.06 to $617.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":31593,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376242,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":734,"price":616.4,"value":452437.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 734 shares of Company stock on February 23, 2022 at prices ranging from $616.14 to $616.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":32769,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376241,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":300,"price":615.2,"value":184560.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on February 23, 2022 at prices ranging from $615.03 to $615.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":33503,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376240,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":600,"price":614.53,"value":368718.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 600 shares of Company stock on February 23, 2022 at prices ranging from $614.02 to $614.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":33803,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376239,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":600,"price":612.44,"value":367464.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 600 shares of Company stock on February 23, 2022 at prices ranging from $612.03 to $612.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":34403,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376238,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":800,"price":611.65,"value":489320.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 800 shares of Company stock on February 23, 2022 at prices ranging from $611.30 to $611.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":35003,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}},{"id":2376237,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":71845,"kind":"person","name":"Van Plew Daniel P","position":1,"cik":"0001411984","reported_name":"Van Plew Daniel P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Mgr, Industrial"}}],"security":"Common Stock","published_at":"2022-02-24T21:11:14.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":200,"price":610.41,"value":122082.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on February 23, 2022 at prices ranging from $610.30 to $610.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2022 at each separate price."}],"balance_after":35803,"source":{"system":"sec-edgar","filing":"0001708138-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000018/edgardoc.xml","form_type":"4"}}],"next_cursor":"2022-02-24T21:11:14.000000Z,2376237"}